{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T15:19:51Z","timestamp":1787584791242,"version":"build-2736575974"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2024,3,30]],"date-time":"2024-03-30T00:00:00Z","timestamp":1711756800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,3,30]],"date-time":"2024-03-30T00:00:00Z","timestamp":1711756800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Beijing Medical Award Foundation","award":["YXJL-2020-1225-0323"],"award-info":[{"award-number":["YXJL-2020-1225-0323"]}]},{"name":"Haiyan Foundation of Harbin Medical University Cancer Hospital","award":["JJZD2020-10"],"award-info":[{"award-number":["JJZD2020-10"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Transl Oncol"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Purpose<\/jats:title>\n                <jats:p>Metabolic syndrome (MetS), characterized by insulin resistance, is closely associated with the prognosis of various cancer types, but has not been reported in diffuse large B-cell lymphoma (DLBCL). The aim of this study is to examine how other clinicopathological variables and the MetS influence the prognosis of DLBCL.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Clinical and pathological data were collected from 319 patients with DLBCL who were admitted to our hospital between January 2012 and December 2020. The data accessible with SPSS 27.0 enables the utilization of various statistical methods for clinical data analysis, including independent sample <jats:italic>t<\/jats:italic> test and univariate and multivariate COX regression.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>The presence of MetS was linked to both overall survival (OS) and progression-free survival (PFS), in addition to other clinicopathological characteristics as age, IPI score, rituximab usage, and Ki-67 expression level. This link with OS and PFS indicated a poor prognosis, as shown by survival analysis. Subsequent univariate analysis identified IPI score, Ki-67 expression level, tumor staging, rituximab usage, lactate dehydrogenase expression level, and the presence or absence of MetS as factors linked with OS and PFS. Furthermore, multivariate Cox regression analysis confirmed the independent risk factor status of IPI score, Ki-67 expression level, rituximab usage, and the presence of MetS in evaluating the prognosis of patients with DLBCL.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>This study\u2019s findings indicate that patients with pre-treatment MetS had a poor prognosis, with relatively shorter OS and PFS compared to those without pre-treatment MetS. Furthermore, the presence of MetS, IPI score, Ki-67 expression level, and rituximab usage were identified as independent risk factors significantly affecting the prognosis of DLBCL.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s12094-024-03438-z","type":"journal-article","created":{"date-parts":[[2024,3,30]],"date-time":"2024-03-30T08:01:45Z","timestamp":1711785705000},"page":"2240-2249","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["The effect of metabolic syndrome on prognosis of diffuse large B-cell lymphoma"],"prefix":"10.1007","volume":"26","author":[{"given":"Wenjing","family":"Xiong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liru","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue","family":"Hui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongbin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2286-8866","authenticated-orcid":false,"given":"Yue","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,3,30]]},"reference":[{"issue":"1","key":"3438_CR1","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3322\/caac.21763","volume":"73","author":"RL Siegel","year":"2023","unstructured":"Siegel RL, Miller KD, Wagle NS, Jemal A. Cancer statistics. CA Cancer J Clin. 2023;73(1):17\u201348.","journal-title":"CA Cancer J Clin"},{"issue":"8","key":"3438_CR2","doi-asserted-by":"publisher","first-page":"2151","DOI":"10.1038\/s41375-021-01285-3","volume":"35","author":"MYR HeKridel","year":"2021","unstructured":"HeKridel MYR. Treatment resistance in diffuse large B-cell lymphoma. Leukemia. 2021;35(8):2151\u201365.","journal-title":"Leukemia"},{"issue":"1","key":"3438_CR3","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/s0899-9007(96)00380-2","volume":"13","author":"GM Reaven","year":"1997","unstructured":"Reaven GM. Banting Lecture 1988. Role of insulin resistance in human disease. Nutrition. 1997;13(1):65. https:\/\/doi.org\/10.1016\/s0899-9007(96)00380-2. (discussion 64, 66).","journal-title":"Nutrition"},{"issue":"16","key":"3438_CR4","doi-asserted-by":"publisher","first-page":"1640","DOI":"10.1161\/circulationaha.109.192644","volume":"120","author":"KGRHSMPZJIKA AlbertiEckelGrundyZimmetCleemanDona","year":"2009","unstructured":"AlbertiEckelGrundyZimmetCleemanDonato KGRHSMPZJIKA, et al. Harmonizing the metabolic syndrome: a joint interim statement of the international diabetes federation task force on epidemiology and prevention; national heart, lung, and blood institute; American heart association; world heart federation; international atherosclerosis society; and international association for the study of obesity. Circulation. 2009;120(16):1640\u20135. https:\/\/doi.org\/10.1161\/circulationaha.109.192644.","journal-title":"Circulation"},{"issue":"13","key":"3438_CR5","doi-asserted-by":"publisher","first-page":"2535","DOI":"10.1002\/cncr.30637","volume":"123","author":"EMC Feliciano","year":"2017","unstructured":"Feliciano EMC, Kwan ML, Kushi LH, Chen WY, Weltzien EK, Castillo AL, et al. Body mass index, PAM50 subtype, recurrence, and survival among patients with nonmetastatic breast cancer. Cancer. 2017;123(13):2535\u201342. https:\/\/doi.org\/10.1002\/cncr.30637.","journal-title":"Cancer"},{"issue":"2","key":"3438_CR6","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1007\/s10549-020-05701-7","volume":"182","author":"GAMCFV BuonoCrispoGiulianoDe AngelisSchett","year":"2020","unstructured":"BuonoCrispoGiulianoDe AngelisSchettiniForestieri GAMCFV, et al. Metabolic syndrome and early stage breast cancer outcome: results from a prospective observational study. Breast Cancer Res Treat. 2020;182(2):401\u20139. https:\/\/doi.org\/10.1007\/s10549-020-05701-7.","journal-title":"Breast Cancer Res Treat"},{"issue":"3","key":"3438_CR7","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1007\/s10549-010-0990-0","volume":"123","author":"MMJH ProtaniCooryMartin","year":"2010","unstructured":"ProtaniCooryMartin MMJH. Effect of obesity on survival of women with breast cancer: systematic review and meta-analysis. Breast Cancer Res Treat. 2010;123(3):627\u201335. https:\/\/doi.org\/10.1007\/s10549-010-0990-0.","journal-title":"Breast Cancer Res Treat"},{"issue":"4","key":"3438_CR8","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1634\/theoncologist.2011-0412","volume":"17","author":"WW Chen","year":"2012","unstructured":"Chen WW, Shao YY, Shau WY, Lin ZZ, Lu YS, Chen HM. The impact of diabetes mellitus on prognosis of early breast cancer in Asia. Oncologist. 2012;17(4):485\u201391.","journal-title":"Oncologist"},{"issue":"4","key":"3438_CR9","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1177\/1479164111433578","volume":"9","author":"F Abbasi","year":"2012","unstructured":"Abbasi F, Malhotra D, Mathur A, Reaven GM, Molina CR. Body mass index and waist circumference associate to a comparable degree with insulin resistance and related metabolic abnormalities in South Asian women and me. Diab Vasc Dis Res. 2012;9(4):296\u2013300.","journal-title":"Diab Vasc Dis Res"},{"issue":"1","key":"3438_CR10","doi-asserted-by":"publisher","first-page":"6267","DOI":"10.1038\/s41598-018-24631-5","volume":"8","author":"L Li","year":"2018","unstructured":"Li L, Li Y, Que X, Gao X, Gao Q, Yu M. Prognostic significances of overexpression MYC and\/or BCL2 in R-CHOP-treated diffuse large B-cell lymphoma: A Systematic review and meta-analysis. Sci Rep. 2018;8(1):6267.","journal-title":"Sci Rep"},{"issue":"6","key":"3438_CR11","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1097\/MOU.0000000000001041","volume":"32","author":"F Belladelli","year":"2022","unstructured":"Belladelli F, Montorsi F, Martini A. Metabolic syndrome obesity and cancer risk. Curr Opin Urol. 2022;32(6):594\u20137.","journal-title":"Curr Opin Urol"},{"key":"3438_CR12","doi-asserted-by":"publisher","first-page":"1080054","DOI":"10.3389\/fonc.2022.1080054","volume":"12","author":"Z Zhou","year":"2022","unstructured":"Zhou Z, Zhang Y, Li Y, Jiang C, Wu Y, Shang L. Metabolic syndrome is a risk factor for breast cancer patients receiving neoadjuvant chemotherapy: A case-control study. Front Oncol. 2022;12:1080054. https:\/\/doi.org\/10.3389\/fonc.2022.1080054.","journal-title":"Front Oncol"},{"issue":"4","key":"3438_CR13","doi-asserted-by":"publisher","first-page":"5442","DOI":"10.18632\/aging.202474","volume":"13","author":"Y Li","year":"2021","unstructured":"Li Y, Zhao J, Wu X, Zhang Y, Jin Y, Cai W. Clinical and genomic characteristics of metabolic syndrome in colorectal cancer. Aging. 2021;13(4):5442\u201360.","journal-title":"Aging"},{"key":"3438_CR14","doi-asserted-by":"publisher","first-page":"143","DOI":"10.2147\/IJGM.S346972","volume":"15","author":"Q Zhang","year":"2022","unstructured":"Zhang Q, Chen P, Tian R, He J, Han Q, Fan L. Metabolic syndrome is an independent risk factor for fuhrman grade and TNM stage of renal clear cell carcinoma. Int J Gen Med. 2022;15:143\u201350.","journal-title":"Int J Gen Med"},{"issue":"11","key":"3438_CR15","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1210\/clinem\/dgaa596","volume":"105","author":"S Sin","year":"2020","unstructured":"Sin S, Lee CH, Choi SM, Han KD, Lee J. Metabolic syndrome and risk of lung cancer: an analysis of Korean national health insurance corporation database. J Clin Endocrinol Metab. 2020;105(11):596.","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"3438_CR16","first-page":"825","volume":"4","author":"AA Siviero-Miachon","year":"2008","unstructured":"Siviero-Miachon AA, Spinola-Castro AM, Guerra G. Detection of metabolic syndrome features among childhood cancer survivors: a target to prevent disease. Vasc Health Risk Manag. 2008;4(4):825\u201336.","journal-title":"Vasc Health Risk Manag"},{"key":"3438_CR17","doi-asserted-by":"publisher","first-page":"556","DOI":"10.3389\/fonc.2018.00556","volume":"8","author":"JE Ricci","year":"2018","unstructured":"Ricci JE, Chiche J. Metabolic Reprogramming of Non-Hodgkin\u2019s B-Cell Lymphomas and Potential Therapeutic Strategies. Front Oncol. 2018;8:556. https:\/\/doi.org\/10.3389\/fonc.2018.00556.","journal-title":"Front Oncol"},{"issue":"7","key":"3438_CR18","doi-asserted-by":"publisher","first-page":"727","DOI":"10.2217\/bmm-2017-0322","volume":"12","author":"JJ Fantony","year":"2018","unstructured":"Fantony JJ, Howard LE, Csizmadi I, Armstrong AJ, Lark AL, Galet C. Is Ki67 prognostic for aggressive prostate cancer? A multicenter real-world study. Biomark Med. 2018;12(7):727\u201336.","journal-title":"Biomark Med"},{"issue":"3","key":"3438_CR19","doi-asserted-by":"publisher","first-page":"285","DOI":"10.4093\/dmj.2020.0250","volume":"45","author":"AMY Zhang","year":"2021","unstructured":"Zhang AMY, Wellberg EA, Kopp JL, Johnson JD. Hyperinsulinemia in obesity, inflammation, and cancer. Diabetes Metab J. 2021;45(3):285\u2013311.","journal-title":"Diabetes Metab J"},{"issue":"3","key":"3438_CR20","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1007\/s00125-020-05338-7","volume":"64","author":"IY Gong","year":"2021","unstructured":"Gong IY, Cheung MC, Read S, Na Y, Lega IC, Lipscombe LL. Association between diabetes and haematological malignancies: a population-based study. Diabetologia. 2021;64(3):540\u201351.","journal-title":"Diabetologia"},{"issue":"2","key":"3438_CR21","first-page":"75","volume":"17","author":"S Atak","year":"2023","unstructured":"Atak S, Serin S, Demirel N, Dogan EE, Ayd\u0131n D, Nizam N. The obesity controversy: does it impact treatment response in diffuse large B-cell lymphoma? Int J Hematol Oncol Stem Cell Res. 2023;17(2):75\u201380.","journal-title":"Int J Hematol Oncol Stem Cell Res"},{"issue":"2","key":"3438_CR22","first-page":"475","volume":"13","author":"T Yu","year":"2023","unstructured":"Yu T, Luo D, Luo C, Xu-Monette ZY, Yu L. Prognostic and therapeutic value of serum lipids and a new IPI score system based on apolipoprotein A-I in diffuse large B-cell lymphoma. Am J Cancer Res. 2023;13(2):475\u201384.","journal-title":"Am J Cancer Res"},{"issue":"3","key":"3438_CR23","first-page":"837","volume":"58","author":"AM P\u0103tra\u015fcu","year":"2017","unstructured":"P\u0103tra\u015fcu AM, Rotaru I, Olar L, P\u0103tra\u015fcu S, Ghilu\u015fi MC, Neam\u0163u SD. The prognostic role of in diffuse large cell lymphoma. Rom J Morphol Embryol. 2017;58(3):837\u201343.","journal-title":"Rom J Morphol Embryol"},{"key":"3438_CR24","doi-asserted-by":"publisher","first-page":"6527457","DOI":"10.1155\/2019\/6527457","volume":"2019","author":"RN Mafiana","year":"2019","unstructured":"Mafiana RN, Al-Kindi MS, Mafiana N, Al Lawati AS, Al Moundhri M. Impact of metabolic syndrome diagnosis and its treatment on survival of colorectal cancer patients. J Cancer Epidemiol. 2019;2019:6527457.","journal-title":"J Cancer Epidemiol"},{"issue":"8","key":"3438_CR25","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.4254\/wjh.v7.i8.1105","volume":"7","author":"J Ampuero","year":"2015","unstructured":"Ampuero J, Romero-Gomez M. Prevention of hepatocellular carcinoma by correction of metabolic abnormalities: Role of statins and metformin. World J Hepatol. 2015;7(8):1105\u20131011.","journal-title":"World J Hepatol"}],"container-title":["Clinical and Translational Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12094-024-03438-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12094-024-03438-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12094-024-03438-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,19]],"date-time":"2024-08-19T21:04:25Z","timestamp":1724101465000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12094-024-03438-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,30]]},"references-count":25,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2024,9]]}},"alternative-id":["3438"],"URL":"https:\/\/doi.org\/10.1007\/s12094-024-03438-z","relation":{},"ISSN":["1699-3055"],"issn-type":[{"value":"1699-3055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,30]]},"assertion":[{"value":"23 January 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 March 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 March 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The studies involving human participants were reviewed and approved by Ethics committee of Harbin Medical University Cancer Hospital. The patients\/participants provided their written informed consent to participate in this study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and Informed consent"}}]}}